{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:21:25Z","timestamp":1788355285576,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Special Fund for Discipline Innovation and Development of the Third Medical Center of Chinese PLA General Hospital","award":["2024BJ-14"],"award-info":[{"award-number":["2024BJ-14"]}]},{"name":"The Traditional Chinese and Western Medicine Collaborative Chronic Disease Management Research Project Fund","award":["CXZH2024080"],"award-info":[{"award-number":["CXZH2024080"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["2024ZD0532301"],"award-info":[{"award-number":["2024ZD0532301"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03000-9","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T04:01:20Z","timestamp":1754884880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis"],"prefix":"10.1186","volume":"30","author":[{"given":"Yuting","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinJin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"5","key":"3000_CR1","first-page":"452","volume":"28","author":"JY Wang","year":"2020","unstructured":"Wang JY, Wei L, Huang Y, Dong JH. Progress in antiviral treatment of hepatitis C after liver transplantation. Zhonghua Gan Zang Bing Za Zhi. 2020;28(5):452\u20136.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"3000_CR2","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.dmpk.2021.100423","volume":"42","author":"K Itohara","year":"2022","unstructured":"Itohara K, Yano I, Nakagawa S, Yonezawa A, Omura T, Imai S, Nakagawa T, Sawada A, Kobayashi T, Tochio A, Sakai K, Taura K, Ogawa O, Matsubara K. Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients. Drug Metab Pharmacokinet. 2022;42:100423.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"3000_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5500\/wjt.v13.i5.254","volume":"13","author":"MC Morais","year":"2023","unstructured":"Morais MC, Soares ME, Costa G, Guerra L, Vaz N, Codes L, Bittencourt PL. Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation. World J Transplant. 2023;13(5):254\u201363.","journal-title":"World J Transplant"},{"issue":"1","key":"3000_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/tri.13777","volume":"34","author":"H Ro","year":"2021","unstructured":"Ro H, Jeong JC, Kong JM, Min JW, Park SK, Lee J, Koo TY, Yang J, Kim MS, Hwang S, Ahn C. The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data. Transpl Int. 2021;34(1):163\u201374.","journal-title":"Transpl Int"},{"issue":"12","key":"3000_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa EZ. Human gut microbiota\/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019\u201340.","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"3000_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/met.2022.0049","volume":"21","author":"N Safari-Alighiarloo","year":"2023","unstructured":"Safari-Alighiarloo N, Emami Z, Rezaei-Tavirani M, Alaei-Shahmiri F, Razavi S. Gut microbiota and their associated metabolites in diabetes: a cross talk between host and microbes-a review. Metab Syndr Relat Disord. 2023;21(1):3\u201315.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"3000_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1210\/er.2015-1084","volume":"37","author":"V Shivaswamy","year":"2016","unstructured":"Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev. 2016;37(1):37\u201361.","journal-title":"Endocr Rev"},{"issue":"7","key":"3000_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","volume":"133","author":"PX Wang","year":"2020","unstructured":"Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020;133(7):808\u201316.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"3000_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/biom11101414","volume":"11","author":"J Gojda","year":"2021","unstructured":"Gojda J, Cahova M. Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules. 2021;11(10):1414.","journal-title":"Biomolecules"},{"issue":"3","key":"3000_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen JCA, van Laar JM. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol. 2020;16(3):167\u201378.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"3000_CR11","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","volume":"80","author":"F Rusnak","year":"2000","unstructured":"Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000;80(4):1483\u2013521.","journal-title":"Physiol Rev"},{"issue":"1","key":"3000_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/FTD.0000000000001288","volume":"47","author":"S Pattanaik","year":"2025","unstructured":"Pattanaik S, Monchaud C. Pharmacokinetic boosting of calcineurin inhibitors in transplantation: pros, cons, and perspectives. Ther Drug Monit. 2025;47(1):118\u201340.","journal-title":"Ther Drug Monit"},{"key":"3000_CR13","doi-asserted-by":"publisher","unstructured":"Oda Y, Nishi H, Hamano F, Yoshida T, Kita Y, Kopp JB, Nangaku M. Calcineurin inhibition deactivates pyruvate dehydrogenase and induces proximal tubule cell metabolic dysfunction, causing profibrotic phenotype. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.11.20.624584.","DOI":"10.1101\/2024.11.20.624584"},{"issue":"18","key":"3000_CR14","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/cells12182269","volume":"12","author":"A Nolze","year":"2023","unstructured":"Nolze A, Matern S, Grossmann C. Calcineurin is a universal regulator of vessel function-focus on vascular smooth muscle cells. Cells. 2023;12(18):2269.","journal-title":"Cells"},{"issue":"1","key":"3000_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah K, Al-Haidari A, Sun J, Kazi JU. T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther. 2021;6(1):412.","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"3000_CR16","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1021\/bi00188a015","volume":"33","author":"PM Stemmer","year":"1994","unstructured":"Stemmer PM, Klee CB. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry. 1994;33(22):6859\u201366.","journal-title":"Biochemistry"},{"issue":"18","key":"3000_CR17","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1101\/gad.1102703","volume":"17","author":"PG Hogan","year":"2003","unstructured":"Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17(18):2205\u201332.","journal-title":"Genes Dev"},{"issue":"6","key":"3000_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1159\/000351648","volume":"37","author":"N Issa","year":"2013","unstructured":"Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol. 2013;37(6):602\u201312.","journal-title":"Am J Nephrol"},{"key":"3000_CR19","doi-asserted-by":"publisher","first-page":"1331800","DOI":"10.3389\/fphar.2024.1331800","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Zhou J, Niu Q, Wang H. Mechanism of tacrolimus in the treatment of lupus nephritis. Front Pharmacol. 2024;15:1331800.","journal-title":"Front Pharmacol"},{"key":"3000_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.phrs.2017.10.012","volume":"128","author":"FK Wallner","year":"2018","unstructured":"Wallner FK, Hultquist Hopkins M, Woodworth N, Lindvall Bark T, Olofsson P, Tilevik A. Correlation and cluster analysis of immunomodulatory drugs based on cytokine profiles. Pharmacol Res. 2018;128:244\u201351.","journal-title":"Pharmacol Res"},{"key":"3000_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","volume":"16","author":"S Ghosh","year":"1998","unstructured":"Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225\u201360.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"3000_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/j.1460-2075.1994.tb06329.x","volume":"13","author":"B Frantz","year":"1994","unstructured":"Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O\u2019Keefe SJ, O\u2019Neill EA. Calcineurin acts in synergy with PMA to inactivate I kappa B\/MAD3, an inhibitor of NF-kappa B. EMBO J. 1994;13(4):861\u201370.","journal-title":"EMBO J"},{"key":"3000_CR23","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"3000_CR24","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/MCB.23.18.6442-6454.2003","volume":"23","author":"CC Wu","year":"2003","unstructured":"Wu CC, Hsu SC, Shih HM, Lai MZ. Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells. Mol Cell Biol. 2003;23(18):6442\u201354.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"3000_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/embo-reports\/kvd090","volume":"1","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep. 2000;1(5):428\u201334.","journal-title":"EMBO Rep"},{"issue":"1","key":"3000_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/imr.12740","volume":"288","author":"W Song","year":"2019","unstructured":"Song W, Craft J. T follicular helper cell heterogeneity: time, space, and function. Immunol Rev. 2019;288(1):85\u201396.","journal-title":"Immunol Rev"},{"key":"3000_CR27","doi-asserted-by":"publisher","first-page":"9794235","DOI":"10.34133\/2022\/9794235","volume":"2022","author":"J Shen","year":"2022","unstructured":"Shen J, Liu C, Yan P, Wang M, Guo L, Liu S, Chen J, Rosenholm JM, Huang H, Wang R, Zhang H. Helper T cell (CD4(+)) targeted tacrolimus delivery mediates precise suppression of allogeneic humoral immunity. Research. 2022;2022:9794235.","journal-title":"Research"},{"issue":"3","key":"3000_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s40472-014-0019-4","volume":"1","author":"CC Baan","year":"2014","unstructured":"Baan CC, de Graav GN, Boer K. T follicular helper cells in transplantation: the target to attenuate antibody-mediated allogeneic responses? Curr Transplant Rep. 2014;1(3):166\u201372.","journal-title":"Curr Transplant Rep"},{"issue":"10","key":"3000_CR29","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1016\/j.transproceed.2019.08.039","volume":"51","author":"R Kraaijeveld","year":"2019","unstructured":"Kraaijeveld R, Li Y, Yan L, de Leur K, Dieterich M, Peeters AMA, Wang L, Shi Y, Baan CC. Inhibition of T helper cell differentiation by Tacrolimus or Sirolimus results in reduced B-cell activation: effects on T follicular helper cells. Transplant Proc. 2019;51(10):3463\u201373.","journal-title":"Transplant Proc"},{"issue":"1","key":"3000_CR30","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1038\/s41467-023-43427-4","volume":"14","author":"MA Podesta","year":"2023","unstructured":"Podesta MA, Cavazzoni CB, Hanson BL, Bechu ED, Ralli G, Clement RL, Zhang H, Chandrakar P, Lee JM, Reyes-Robles T, Abdi R, Diallo A, Sen DR, Sage PT. Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states. Nat Commun. 2023;14(1):7712.","journal-title":"Nat Commun"},{"issue":"6","key":"3000_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","volume":"49","author":"H Lee","year":"2023","unstructured":"Lee H, Myoung H, Kim SM. Review of two immunosuppressants: tacrolimus and cyclosporine. J Korean Assoc Oral Maxillofac Surg. 2023;49(6):311\u201323.","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"1","key":"3000_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.intimp.2014.05.004","volume":"21","author":"Y Ren","year":"2014","unstructured":"Ren Y, Yang Y, Yang J, Xie R, Fan H. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. Int Immunopharmacol. 2014;21(1):247\u201354.","journal-title":"Int Immunopharmacol"},{"key":"3000_CR33","doi-asserted-by":"publisher","first-page":"e2597","DOI":"10.6061\/clinics\/2021\/e2597","volume":"76","author":"F Tustumi","year":"2021","unstructured":"Tustumi F, Miranda Neto AA, Silveira J\u00fanior S, Fernandes FA, Silva M, Ernani L, Nacif LS, Coelho FF, Andraus W, Bernardo WM, Herman P, Carneiro-D\u2019Albuquerque LA. Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials. Clinics (Sao Paulo, Brazil). 2021;76:e2597.","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"2","key":"3000_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10059-009-0114-z","volume":"28","author":"K Kogina","year":"2009","unstructured":"Kogina K, Shoda H, Yamaguchi Y, Tsuno NH, Takahashi K, Fujio K, Yamamoto K. Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells. Mol Cells. 2009;28(2):125\u201330.","journal-title":"Mol Cells"},{"issue":"2","key":"3000_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/aor.13551","volume":"44","author":"Y Bentata","year":"2020","unstructured":"Bentata Y. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity. Artif Organs. 2020;44(2):140\u201352.","journal-title":"Artif Organs"},{"issue":"6","key":"3000_CR36","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/bcp.15946","volume":"91","author":"S Udomkarnjananun","year":"2025","unstructured":"Udomkarnjananun S, Eiamsitrakoon T, de Winter BCM, van Gelder T, Hesselink DA. Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements? Br J Clin Pharmacol. 2025;91(6):1530\u201341.","journal-title":"Br J Clin Pharmacol"},{"key":"3000_CR37","doi-asserted-by":"publisher","unstructured":"Wu G, Weng FL, Balaraman V. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Rep. 2013. https:\/\/doi.org\/10.1136\/bcr-2013-201099.","DOI":"10.1136\/bcr-2013-201099"},{"key":"3000_CR38","doi-asserted-by":"crossref","unstructured":"Guo T, Lei J, Gao J, Li Z, Liu Z. The hepatic protective effects of tacrolimus as a rinse solution in liver transplantation: a meta-analysis. Medicine (Baltimore). 2019;98(21):e15809.","DOI":"10.1097\/MD.0000000000015809"},{"issue":"1","key":"3000_CR39","doi-asserted-by":"publisher","first-page":"20236","DOI":"10.1038\/s41598-023-46803-8","volume":"13","author":"DG Kim","year":"2023","unstructured":"Kim DG, Yim SH, Min EK, Choi MC, Joo DJ, Kim MS, Lee JG. Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma. Sci Rep. 2023;13(1):20236.","journal-title":"Sci Rep"},{"issue":"1","key":"3000_CR40","first-page":"362","volume":"27","author":"K Kawano","year":"1995","unstructured":"Kawano K, Bowers JL, Clouse ME. Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. Transplant Proc. 1995;27(1):362\u20133.","journal-title":"Transplant Proc"},{"issue":"1","key":"3000_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0039-6060(99)70284-9","volume":"125","author":"Y Soda","year":"1999","unstructured":"Soda Y, El-Assal ON, Yu L, Nagasue N. Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia\/reperfusion of rat small intestine. Surgery. 1999;125(1):23\u201332.","journal-title":"Surgery"},{"issue":"1","key":"3000_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jss.2011.07.045","volume":"176","author":"S Pratschke","year":"2012","unstructured":"Pratschke S, Bilzer M, Gr\u00fctzner U, Angele M, Tufman A, Jauch KW, Schauer RJ. Tacrolimus preconditioning of rat liver allografts impacts glutathione homeostasis and early reperfusion injury. J Surg Res. 2012;176(1):309\u201316.","journal-title":"J Surg Res"},{"issue":"1","key":"3000_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1172\/JCI111182","volume":"73","author":"BH Lauterburg","year":"1984","unstructured":"Lauterburg BH, Smith CV, Hughes H, Mitchell JR. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J Clin Investig. 1984;73(1):124\u201333.","journal-title":"J Clin Investig"},{"issue":"5\u20136","key":"3000_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0006-2952(02)01172-3","volume":"64","author":"DA Dickinson","year":"2002","unstructured":"Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol. 2002;64(5\u20136):1019\u201326.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3000_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12906-022-03803-x","volume":"22","author":"F Terzi","year":"2022","unstructured":"Terzi F, Ciftci MK. Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity. BMC Complement Med Ther. 2022;22(1):331.","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"3000_CR46","doi-asserted-by":"publisher","first-page":"e14226","DOI":"10.1111\/petr.14226","volume":"26","author":"L \u00c9boli","year":"2022","unstructured":"\u00c9boli L, Tannuri ACA, Tannuri U. Seropositivity for cytomegalovirus and PCR-EBV monitoring: protective factors for posttransplant lymphoproliferative disorder in pediatric liver transplant. Pediatr Transplant. 2022;26(4):e14226.","journal-title":"Pediatr Transplant"},{"issue":"5","key":"3000_CR47","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/TP.0000000000002634","volume":"103","author":"P Kron","year":"2019","unstructured":"Kron P, Schlegel A, Muller X, Gaspert A, Clavien PA, Dutkowski P. Hypothermic oxygenated perfusion: a simple and effective method to modulate the immune response in kidney transplantation. Transplantation. 2019;103(5):e128\u201336.","journal-title":"Transplantation"},{"key":"3000_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.028","author":"P Kron","year":"2017","unstructured":"Kron P, Schlegel A, Mancina L, Clavien PA, Dutkowski P. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2017. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.028.","journal-title":"J Hepatol"},{"issue":"2","key":"3000_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2012.10.004","volume":"58","author":"A Schlegel","year":"2013","unstructured":"Schlegel A, de Rougemont O, Graf R, Clavien PA, Dutkowski P. Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts. J Hepatol. 2013;58(2):278\u201386.","journal-title":"J Hepatol"},{"issue":"5","key":"3000_CR50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills EL, Kelly B, O\u2019Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18(5):488\u201398.","journal-title":"Nat Immunol"},{"issue":"3","key":"3000_CR51","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/bcp.15563","volume":"89","author":"N Riva","year":"2023","unstructured":"Riva N, Ibarra M, Parra-Guillen ZP, Galv\u00e1n ME, P\u00e9rez E, Trezeguet Renatti G, C\u00e1ceres Guido P, Lopez C, Licciardone N, Halac E, Dip M, Cruz A, Imventarza O, Buamscha D, Troconiz IF, Schaiquevich P. Population pharmacokinetics of sublingually administered tacrolimus in infants and young children with liver transplantation. Br J Clin Pharmacol. 2023;89(3):1115\u201326.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"3000_CR52","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/biomedicines11071792","volume":"11","author":"L Abenavoli","year":"2023","unstructured":"Abenavoli L, Scarlata GGM, Paravati MR, Boccuto L, Luzza F, Scarpellini E. Gut microbiota and liver transplantation: immune mechanisms behind the rejection. Biomedicines. 2023;11(7):1792.","journal-title":"Biomedicines"},{"issue":"11","key":"3000_CR53","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823\u201336.","journal-title":"Biochem J"},{"issue":"1","key":"3000_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.","journal-title":"Microorganisms"},{"issue":"2","key":"3000_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","volume":"55","author":"H Hu","year":"2020","unstructured":"Hu H, Lin A, Kong M, Yao X, Yin M, Xia H, Ma J, Liu H. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. J Gastroenterol. 2020;55(2):142\u201358.","journal-title":"J Gastroenterol"},{"issue":"1","key":"3000_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1499-3872(11)60124-0","volume":"11","author":"ZW Wu","year":"2012","unstructured":"Wu ZW, Ling ZX, Lu HF, Zuo J, Sheng JF, Zheng SS, Li LJ. Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int. 2012;11(1):40\u201350.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"3000_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.dld.2023.06.017","volume":"56","author":"S Adhikary","year":"2024","unstructured":"Adhikary S, Esmeeta A, Dey A, Banerjee A, Saha B, Gopan P, Duttaroy AK, Pathak S. Impacts of gut microbiota alteration on age-related chronic liver diseases. Dig Liver Dis. 2024;56(1):112\u201322.","journal-title":"Dig Liver Dis"},{"key":"3000_CR58","doi-asserted-by":"publisher","first-page":"1266635","DOI":"10.3389\/fphys.2023.1266635","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang R, Qiu W, Sun X, Li J, Geng X, Yu S, Liu Y, Huang H, Li M, Fan Z, Li M, Lv G. Gut microbiota dynamics in a 1-year follow-up after adult liver transplantation in Northeast China. Front Physiol. 2023;14:1266635.","journal-title":"Front Physiol"},{"issue":"6","key":"3000_CR59","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/lt.25046","volume":"24","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Kakiyama G, Cox IJ, Nittono H, Takei H, White M, Fagan A, Gavis EA, Heuman DM, Gilles HC, Hylemon P, Taylor-Robinson SD, Legido-Quigley C, Kim M, Xu J, Williams R, Sikaroodi M, Pandak WM, Gillevet PM. Alterations in gut microbial function following liver transplant. Liver Transpl. 2018;24(6):752\u201361.","journal-title":"Liver Transpl"},{"issue":"5","key":"3000_CR60","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.hbpd.2023.07.002","volume":"22","author":"L Jiang","year":"2023","unstructured":"Jiang L, Xu J, Cheng SY, Wang Y, Cai W. The gut microbiome and intestinal failure-associated liver disease. Hepatobiliary Pancreat Dis Int. 2023;22(5):452\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"21","key":"3000_CR61","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.12998\/wjcc.v11.i21.4975","volume":"11","author":"O Kriger-Sharabi","year":"2023","unstructured":"Kriger-Sharabi O, Malnick SDH, Fisher D. Manipulation of the intestinal microbiome-a slow journey to primetime. World J Clin Cases. 2023;11(21):4975\u201388.","journal-title":"World J Clin Cases"},{"key":"3000_CR62","doi-asserted-by":"publisher","first-page":"854017","DOI":"10.3389\/fphys.2022.854017","volume":"13","author":"Z Lai","year":"2022","unstructured":"Lai Z, Chen Z, Zhang A, Niu Z, Cheng M, Huo C, Xu J. The gut microbiota in liver transplantation recipients during the perioperative period. Front Physiol. 2022;13:854017.","journal-title":"Front Physiol"},{"issue":"7","key":"3000_CR63","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/ajt.14661","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Liu L, Tang H, Jiao W, Zeng S, Xu Y, Zhang Q, Sun Z, Mukherjee A, Zhang X, Hu X. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am J Transplant. 2018;18(7):1646\u201356.","journal-title":"Am J Transplant"},{"issue":"5","key":"3000_CR64","doi-asserted-by":"publisher","first-page":"e0233646","DOI":"10.1371\/journal.pone.0233646","volume":"15","author":"DL Jennings","year":"2020","unstructured":"Jennings DL, Bohn B, Zuver A, Onat D, Gaine M, Royzman E, Hupf J, Brunjes D, Latif F, Restaino S, Garan AR, Topkara VK, Takayama H, Takeda K, Naka Y, Farr M, Nandakumar R, Uhlemann AC, Colombo PC, Demmer RT, Yuzefpolskaya M. Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. PLoS ONE. 2020;15(5):e0233646.","journal-title":"PLoS ONE"},{"issue":"9","key":"3000_CR65","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/ajt.15880","volume":"20","author":"W Jiao","year":"2020","unstructured":"Jiao W, Zhang Z, Xu Y, Gong L, Zhang W, Tang H, Zeng S, Zhang Q, Sun Z, Liu L, Hu X. Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota. Am J Transpl. 2020;20(9):2413\u201324.","journal-title":"Am J Transpl"},{"key":"3000_CR66","doi-asserted-by":"publisher","first-page":"105191","DOI":"10.1016\/j.micpath.2021.105191","volume":"160","author":"DH Yu","year":"2021","unstructured":"Yu DH, Ying N, Lian ZH, Fa YQ. The alteration human of gut microbiota and metabolites before and after renal transplantation. Microb Pathog. 2021;160:105191.","journal-title":"Microb Pathog"},{"key":"3000_CR67","doi-asserted-by":"publisher","first-page":"177176","DOI":"10.1016\/j.ejphar.2024.177176","volume":"987","author":"C Kunasol","year":"2025","unstructured":"Kunasol C, Chattipakorn N, Chattipakorn SC. Impact of calcineurin inhibitors on gut microbiota: focus on tacrolimus with evidence from in vivo and clinical studies. Eur J Pharmacol. 2025;987:177176.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3000_CR68","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","volume":"70","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 2019;70(2):260\u201372.","journal-title":"J Hepatol"},{"issue":"1","key":"3000_CR69","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40168-023-01578-y","volume":"11","author":"AL Degraeve","year":"2023","unstructured":"Degraeve AL, Haufroid V, Loriot A, Gatto L, Andries V, Vereecke L, Elens L, Bindels LB. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome. 2023;11(1):138.","journal-title":"Microbiome"},{"key":"3000_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041107","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12041107.","journal-title":"Nutrients"},{"issue":"1","key":"3000_CR71","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12967-023-04306-0","volume":"21","author":"G Li","year":"2023","unstructured":"Li G, Feng H, Mao XL, Deng YJ, Wang XB, Zhang Q, Guo Y, Xiao SM. The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials. J Transl Med. 2023;21(1):442.","journal-title":"J Transl Med"},{"issue":"14","key":"3000_CR72","doi-asserted-by":"publisher","first-page":"e1800033","DOI":"10.1002\/mnfr.201800033","volume":"62","author":"M Toral","year":"2018","unstructured":"Toral M, Romero M, Rodriguez-Nogales A, Jimenez R, Robles-Vera I, Algieri F, Chueca-Porcuna N, Sanchez M, de la Visitacion N, Olivares M, Garcia F, Perez-Vizcaino F, Galvez J, Duarte J. Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving eNOS coupling. Mol Nutr Food Res. 2018;62(14):e1800033.","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"3000_CR73","first-page":"CD014804","volume":"9","author":"TE Cooper","year":"2022","unstructured":"Cooper TE, Scholes-Robertson N, Craig JC, Hawley CM, Howell M, Johnson DW, Teixeira-Pinto A, Jaure A, Wong G. Synbiotics, prebiotics and probiotics for solid organ transplant recipients. Cochrane Database Syst Rev. 2022;9(9):CD014804.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3000_CR74","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Liu MD, Zhou HL, Wang YS, Xu ZX. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21(1):212.","journal-title":"Cell Commun Signal"},{"key":"3000_CR75","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.cbpa.2024.102539","volume":"83","author":"PV Chang","year":"2024","unstructured":"Chang PV. Microbial metabolite-receptor interactions in the gut microbiome. Curr Opin Chem Biol. 2024;83:102539.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"3000_CR76","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-024-01552-7","volume":"22","author":"L Yu","year":"2024","unstructured":"Yu L, Lu J, Du W. Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications. Cell Commun Signal. 2024;22(1):174.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3000_CR77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12866-023-03141-z","volume":"23","author":"B Ma","year":"2023","unstructured":"Ma B, Gavzy SJ, France M, Song Y, Lwin HW, Kensiski A, Saxena V, Piao W, Lakhan R, Iyyathurai J, Li L, Paluskievicz C, Wu L, WillsonShirkey M, Mongodin EF, Mas VR, Bromberg JS. Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment. BMC Microbiol. 2023;23(1):394.","journal-title":"BMC Microbiol"},{"issue":"7","key":"3000_CR78","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","volume":"64","author":"J Hjelmesaeth","year":"1997","unstructured":"Hjelmesaeth J, Hartmann A, Kofstad J, Stenstr\u00f8m J, Leivestad T, Egeland T, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997;64(7):979\u201383.","journal-title":"Transplantation"},{"issue":"7","key":"3000_CR79","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1600-6143.2006.01340.x","volume":"6","author":"L Gallon","year":"2006","unstructured":"Gallon L, Perico N, Dimitrov BD, Winoto J, Remuzzi G, Leventhal J, Gaspari F, Kaufman D. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transpl. 2006;6(7):1617\u201323.","journal-title":"Am J Transpl"},{"issue":"1","key":"3000_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ajt.12969","volume":"15","author":"EL Yanik","year":"2015","unstructured":"Yanik EL, Gustafson SK, Kasiske BL, Israni AK, Snyder JJ, Hess GP, Engels EA, Segev DL. Sirolimus use and cancer incidence among US kidney transplant recipients. Am J Transpl. 2015;15(1):129\u201336.","journal-title":"Am J Transpl"},{"issue":"7","key":"3000_CR81","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","volume":"80","author":"HM Kauffman","year":"2005","unstructured":"Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005;80(7):883\u20139.","journal-title":"Transplantation"},{"issue":"1","key":"3000_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12307-010-0041-8","volume":"3","author":"X Ling","year":"2010","unstructured":"Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, Clise-Dwyer K, Wang RY, Zhang W, Yuan X, Lu H, Caldwell L, Andreeff M. Mesenchymal stem cells overexpressing IFN-\u03b2 inhibit breast cancer growth and metastases through Stat3 signaling in a syngeneic tumor model. Cancer Microenviron. 2010;3(1):83\u201395.","journal-title":"Cancer Microenviron"},{"issue":"7","key":"3000_CR83","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674\u201385.","journal-title":"Diabetes Care"},{"issue":"1","key":"3000_CR84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, Xu S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15(1):42.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3000_CR85","doi-asserted-by":"publisher","first-page":"2373467","DOI":"10.1080\/10641963.2024.2373467","volume":"46","author":"X Liu","year":"2024","unstructured":"Liu X, Su Y, Liu J, Liu D, Yu C. Inhibition of Th17 cell differentiation by aerobic exercise improves vasodilatation in diabetic mice. Clin Exp Hypertens. 2024;46(1):2373467.","journal-title":"Clin Exp Hypertens"},{"key":"3000_CR86","doi-asserted-by":"publisher","first-page":"216894","DOI":"10.1016\/j.canlet.2024.216894","volume":"591","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Rabbani SA, Babiker R, Rangraze I, Kapre S, Palakurthi SS, Alnuqaydan AM, Aljabali AA, Rizzo M, El-Tanani Y, Tambuwala MM. Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies. Cancer Lett. 2024;591:216894.","journal-title":"Cancer Lett"},{"issue":"1","key":"3000_CR87","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12672-024-01561-5","volume":"15","author":"R Zhi","year":"2024","unstructured":"Zhi R, Fan F. SLC1A3 is a novel prognostic biomarker associated with immunity and EMT in hepatocellular carcinoma. Discov Oncol. 2024;15(1):676.","journal-title":"Discov Oncol"},{"issue":"1","key":"3000_CR88","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262.","journal-title":"Signal Transduct Target Ther"},{"key":"3000_CR89","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/DMSO.S236127","volume":"13","author":"J Feng","year":"2020","unstructured":"Feng J, Lu S, Ou B, Liu Q, Dai J, Ji C, Zhou H, Huang H, Ma Y. The role of JNk signaling pathway in obesity-driven insulin resistance. Diabetes Metab Syndr Obes Targets Ther. 2020;13:1399\u2013406.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"3000_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.toxlet.2024.05.003","volume":"397","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zeng S, Huang J, Tian X, Wu J, Guo L, Liang Y. Down-regulation of O-GlcNAcylation alleviates insulin signaling pathway impairment following arsenic exposure via suppressing the AMPK\/mTOR-autophagy pathway. Toxicol Lett. 2024;397:67\u201378.","journal-title":"Toxicol Lett"},{"issue":"8","key":"3000_CR91","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4239\/wjd.v13.i8.665","volume":"13","author":"B Zhou","year":"2022","unstructured":"Zhou B, Jin YQ, He LP. Loss of skeletal muscle mass is not specific to type 2 diabetes. World J Diabetes. 2022;13(8):665\u20137.","journal-title":"World J Diabetes"},{"issue":"10","key":"3000_CR92","doi-asserted-by":"publisher","first-page":"a006072","DOI":"10.1101\/cshperspect.a006072","volume":"8","author":"GS Hotamisligil","year":"2016","unstructured":"Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb Perspect Biol. 2016;8(10):a006072.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"3000_CR93","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111\u20139.","journal-title":"J Clin Invest"},{"issue":"6","key":"3000_CR94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.62347\/WAZH2090","volume":"16","author":"M Nakashima","year":"2024","unstructured":"Nakashima M, Suga N, Fukumoto A, Yoshikawa S, Matsuda S. Comprehension of gut microbiota and microRNAs may contribute to the development of innovative treatment tactics against metabolic disorders and psychiatric disorders. Int J Physiol Pathophysiol Pharmacol. 2024;16(6):111\u201325.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"5","key":"3000_CR95","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/nutrit\/nuae157","volume":"83","author":"P Nie","year":"2025","unstructured":"Nie P, Hu L, Feng X, Xu H. Gut microbiota disorders and metabolic syndrome: tales of a crosstalk process. Nutr Rev. 2025;83(5):908\u201324.","journal-title":"Nutr Rev"},{"issue":"3","key":"3000_CR96","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00203-022-02802-3","volume":"204","author":"Q Shi","year":"2022","unstructured":"Shi Q, Dai L, Zhao Q, Zhang X. A review on the effect of gut microbiota on metabolic diseases. Arch Microbiol. 2022;204(3):192.","journal-title":"Arch Microbiol"},{"issue":"2","key":"3000_CR97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chom.2019.07.004","volume":"26","author":"LB Thingholm","year":"2019","unstructured":"Thingholm LB, R\u00fchlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, Bang C, Franzosa EA, H\u00fcbenthal M, Rahnavard A, Frost F, Lloyd-Price J, Schirmer M, Lusis AJ, Vulpe CD, Lerch MM, Homuth G, Kacprowski T, Schmidt CO, N\u00f6thlings U, Karlsen TH, Lieb W, Laudes M, Franke A, Huttenhower C. Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe. 2019;26(2):252-64.e10.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3000_CR98","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1210\/clinem\/dgaa769","volume":"106","author":"SP Mishra","year":"2021","unstructured":"Mishra SP, Jain S, Taraphder S, Yadav H. New horizons in microbiota and metabolic health research. J Clin Endocrinol Metab. 2021;106(2):e1052\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"3000_CR99","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1039\/C9FO01465A","volume":"10","author":"Q Li","year":"2019","unstructured":"Li Q, Chen H, Zhang M, Wu T, Liu R. Altered short chain fatty acid profiles induced by dietary fiber intervention regulate AMPK levels and intestinal homeostasis. Food Funct. 2019;10(11):7174\u201387.","journal-title":"Food Funct"},{"key":"3000_CR100","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.abb.2019.07.022","volume":"672","author":"H Yoshida","year":"2019","unstructured":"Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43\/AMPK signaling pathway. Arch Biochem Biophys. 2019;672:108057.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"3000_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/dom.12811","volume":"19","author":"A Pingitore","year":"2017","unstructured":"Pingitore A, Chambers ES, Hill T, Maldonado IR, Liu B, Bewick G, Morrison DJ, Preston T, Wallis GA, Tedford C, Casta\u00f1era Gonz\u00e1lez R, Huang GC, Choudhary P, Frost G, Persaud SJ. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab. 2017;19(2):257\u201365.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3000_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13(1):1\u201324.","journal-title":"Gut Microbes"},{"issue":"1","key":"3000_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-01746-y","volume":"9","author":"D Semo","year":"2024","unstructured":"Semo D, Reinecke H, Godfrey R. Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal Transduct Target Ther. 2024;9(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"3000_CR104","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.3390\/nu14224774","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Y, Sun Y, Zhang X. Combined physical exercise and diet: regulation of gut microbiota to prevent and treat of metabolic disease: a review. Nutrients. 2022;14(22):4774.","journal-title":"Nutrients"},{"key":"3000_CR105","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/DMSO.S432344","volume":"16","author":"Z Zhuang","year":"2023","unstructured":"Zhuang Z, Zhou P, Wang J, Lu X, Chen Y. The characteristics, mechanisms and therapeutics: exploring the role of gut microbiota in obesity. Diabetes Metab Syndr Obes. 2023;16:3691\u2013705.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"3000_CR106","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","volume":"13","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wang R, Han B, Sun C, Chen R, Wei H, Chen L, Du H, Li G, Yang Y, Chen X, Cui L, Xu Z, Fu J, Wu J, Gu W, Chen Z, Fang X, Yang H, Su Z, Wu J, Li Q, Zhang M, Zhou Y, Zhang L, Ji G, Luo F. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13(1):6356.","journal-title":"Nat Commun"},{"issue":"2","key":"3000_CR107","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/ijms24021260","volume":"24","author":"J Przybyci\u0144ski","year":"2023","unstructured":"Przybyci\u0144ski J, Dro\u017cd\u017cal S, Wilk A, Dziedziejko V, Szumilas K, Pawlik A. The effect of the gut microbiota on transplanted kidney function. Int J Mol Sci. 2023;24(2):1260.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3000_CR108","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2174\/1389200222666211015153317","volume":"22","author":"A Radhakrishnan","year":"2021","unstructured":"Radhakrishnan A, Kuppusamy G. Theoretical formulation strategies towards neutralizing inter-individual variability associated with Tacrolimus immunosuppressant therapy: a case study on nextgeneration personalized medicine. Curr Drug Metab. 2021;22(12):939\u201356.","journal-title":"Curr Drug Metab"},{"key":"3000_CR109","doi-asserted-by":"publisher","DOI":"10.1080\/17460913.2024.2444761","author":"M Qian","year":"2024","unstructured":"Qian M, Jiang Z, Xu C, Wang L, Hu N. Changes in the gut microbiota and derived fecal metabolites may play a role in tacrolimus-induced diabetes in mice. Future Microbiol. 2024. https:\/\/doi.org\/10.1080\/17460913.2024.2444761.","journal-title":"Future Microbiol"},{"issue":"1","key":"3000_CR110","doi-asserted-by":"publisher","first-page":"2310277","DOI":"10.1080\/19490976.2024.2310277","volume":"16","author":"P Li","year":"2024","unstructured":"Li P, Zhang R, Zhou J, Guo P, Liu Y, Shi S. Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activity. Gut Microbes. 2024;16(1):2310277.","journal-title":"Gut Microbes"},{"issue":"1","key":"3000_CR111","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s10020-024-01033-0","volume":"30","author":"W Yao","year":"2024","unstructured":"Yao W, Huo J, Ji J, Liu K, Tao P. Elucidating the role of gut microbiota metabolites in diabetes by employing network pharmacology. Mol Med. 2024;30(1):263.","journal-title":"Mol Med"},{"issue":"7978","key":"3000_CR112","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","volume":"621","author":"T Takeuchi","year":"2023","unstructured":"Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon AT, Yazaki J, Ikeda K, Nemoto S, Mochizuki Y, Kitami T, Yugi K, Mizuno Y, Yamamichi N, Yamazaki T, Takamoto I, Kubota N, Kadowaki T, Arner E, Carninci P, Ohara O, Arita M, Hattori M, Koyasu S, Ohno H. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621(7978):389\u201395.","journal-title":"Nature"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03000-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:02:28Z","timestamp":1763517748000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3000"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03000-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Affiliations have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"731"}}